CELSTAT

Biological BAXTER HEALTHCARE
Total Payments
$798,467
Transactions
97
Doctors
5
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2018 $56,916 29 5
2017 $741,551 68 0

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $796,048 92 99.7%
Consulting Fee $2,355 2 0.3%
Food and Beverage $63.75 3 0.0%

Payments by Type

Research
$796,048
92 transactions
General
$2,419
5 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Effectiveness and Safety of CELSTAT for Hemostasis in Intraoperative Tissue Bleeding BAXTER HEALTHCARE $741,551 0
Effectiveness and Safety of CELSTAT for Hemostasis in Intraoperative Tissue Bleeding -CELSTAT- - 3584001 Baxter Healthcare $29,438 0
Effectiveness and Safety of CELSTAT for Hemostasis in Intraoperative Tissue Bleeding -CELSTAT- - 3584001 BAXTER HEALTHCARE $25,059 0

Top Doctors Receiving Payments for CELSTAT

Doctor Specialty Location Total Records
Unknown Pittsburgh, PA $796,048 92
, MD Surgery Louisville, KY $1,395 1
, MD Surgery Miami, FL $960.00 1
, MD Surgery Brandon, FL $21.25 1
, MD Vascular Surgery Brandon, FL $21.25 1
, M.D Student in an Organized Health Care Education/Training Program Brandon, FL $21.25 1

About CELSTAT

CELSTAT is a biological associated with $798,467 in payments to 5 healthcare providers, recorded across 97 transactions in the CMS Open Payments database. The primary manufacturer is BAXTER HEALTHCARE.

Payment data is available from 2017 to 2018. In 2018, $56,916 was paid across 29 transactions to 5 doctors.

The most common payment nature for CELSTAT is "Unspecified" ($796,048, 99.7% of total).

CELSTAT is associated with 3 research studies, including "Effectiveness and Safety of CELSTAT for Hemostasis in Intraoperative Tissue Bleeding" ($741,551).